Abstract
Structural variation, such as deletions, duplications, inversions and complex rearrangements, can have profound effects on gene expression, genome stability, phenotypic diversity and disease susceptibility. Structural variants can encompass up to millions of bases and have the potential to rearrange substantial segments of the genome. They contribute considerably more to genetic diversity in human populations and have larger effects on phenotypic traits than point mutations. Until recently, our understanding of the effects of structural variants was driven mainly by studying naturally occurring variation. New genome-engineering tools capable of generating deletions, insertions, inversions and translocations, together with the discovery of new recombinases and advances in creating synthetic DNA constructs, now enable the design and generation of an extended range of structural variation. Here, we discuss these tools and examples of their application and highlight existing challenges that will need to be overcome to fully harness their potential.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Sudmant, P. H. et al. An integrated map of structural variation in 2,504 human genomes. Nature 526, 75–81 (2015).
Stankiewicz, P. & Lupski, J. R. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 61, 437–455 (2010).
Jacobs, P. A., Baikie, A. G., Court Brown, W. M. & Strong, J. A. The somatic chromosomes in mongolism. Lancet 1, 710 (1959).
Weischenfeldt, J., Symmons, O., Spitz, F. & Korbel, J. O. Phenotypic impact of genomic structural variation: insights from and for human disease. Nat. Rev. Genet. 14, 125–138 (2013).
Stefansson, H. et al. Large recurrent microdeletions associated with schizophrenia. Nature 455, 232–236 (2008).
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature 578, 82–93 (2020).
Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112–121 (2020).
Spielmann, M., Lupiáñez, D. G. & Mundlos, S. Structural variation in the 3D genome. Nat. Rev. Genet. 19, 453–467 (2018).
Stranger, B. E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848–853 (2007).
Chiang, C. et al. The impact of structural variation on human gene expression. Nat. Genet. 49, 692–699 (2017).
Ferraro, N. M. et al. Transcriptomic signatures across human tissues identify functional rare genetic variation. Science 369, eaaz5900 (2020).
Vanderstichele, T. et al. Misexpression of inactive genes in whole blood is associated with nearby rare structural variants. Am. J. Hum. Genet. 111, 1524–1543 (2024).
Vialle, R. A., de Paiva Lopes, K., Bennett, D. A., Crary, J. F. & Raj, T. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain. Nat. Neurosci. 25, 504–514 (2022).
Li, T. et al. The functional impact of rare variation across the regulatory cascade. Cell Genom. 3, 100401 (2023).
Collins, R. L. et al. A structural variation reference for medical and population genetics. Nature 581, 444–451 (2020).
Gao, T. et al. A pan-tissue survey of mosaic chromosomal alterations in 948 individuals. Nat. Genet. 55, 1901–1911 (2023).
Hollox, E. J., Zuccherato, L. W. & Tucci, S. Genome structural variation in human evolution. Trends Genet. 38, 45–58 (2022).
Byrska-Bishop, M. et al. High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios. Cell 185, 3426–3440 (2022).
Belyeu, J. R. et al. De novo structural mutation rates and gamete-of-origin biases revealed through genome sequencing of 2,396 families. Am. J. Hum. Genet. 108, 597–607 (2021).
Scott, A. J., Chiang, C. & Hall, I. M. Structural variants are a major source of gene expression differences in humans and often affect multiple nearby genes. Genome Res. 31, 2249–2257 (2021).
Ramírez-Solis, R., Liu, P. & Bradley, A. Chromosome engineering in mice. Nature 378, 720–724 (1995).
Buchholz, F., Refaeli, Y., Trumpp, A. & Bishop, J. M. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. EMBO Rep. 1, 133–139 (2000).
Collins, E. C., Pannell, R., Simpson, E. M., Forster, A. & Rabbitts, T. H. Inter-chromosomal recombination of Mll and Af9 genes mediated by cre–loxP in mouse development. EMBO Rep. 1, 127–132 (2000).
Anzalone, A. V. et al. Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nat. Biotechnol. 40, 731–740 (2022).
Li, Y. et al. Genome-wide Cas9-mediated screening of essential non-coding regulatory elements via libraries of paired single-guide RNAs. Nat. Biomed. Eng. 8, 890–908 (2024).
Aregger, M., Xing, K. & Gonatopoulos-Pournatzis, T. Application of CHyMErA Cas9–Cas12a combinatorial genome-editing platform for genetic interaction mapping and gene fragment deletion screening. Nat. Protoc. 16, 4722–4765 (2021).
Diao, Y. et al. A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells. Nat. Methods 14, 629–635 (2017).
Brosh, R. et al. A versatile platform for locus-scale genome rewriting and verification. Proc. Natl Acad. Sci. USA 118, e2023952118 (2021).
Hay, D. et al. Genetic dissection of the α-globin super-enhancer in vivo. Nat. Genet. 48, 895–903 (2016).
Blayney, J. W. et al. Super-enhancers include classical enhancers and facilitators to fully activate gene expression. Cell 186, 5826–5839 (2023).
Pinglay, S. et al. Synthetic regulatory reconstitution reveals principles of mammalian cluster regulation. Science 377, eabk2820 (2022).
Pinglay, S. et al. Multiplex generation and single cell analysis of structural variants in a mammalian genome. Preprint at bioRxiv https://doi.org/10.1101/2024.01.22.576756 (2024).
Koeppel, J. et al. Randomizing the human genome by engineering recombination between repeat elements. Preprint at bioRxiv https://doi.org/10.1101/2024.01.22.576745 (2024).
Findlay, G. M. et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature 562, 217–222 (2018).
Radford, E. J. et al. Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation. Nat. Commun. 14, 7702 (2023).
Patwardhan, R. P. et al. High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis. Nat. Biotechnol. 27, 1173–1175 (2009).
Wang, J. Y. & Doudna, J. A. CRISPR technology: a decade of genome editing is only the beginning. Science 379, eadd8643 (2023).
Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019).
Epinat, J.-C. et al. A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells. Nucleic Acids Res. 31, 2952–2962 (2003).
Porteus, M. H. & Carroll, D. Gene targeting using zinc finger nucleases. Nat. Biotechnol. 23, 967–973 (2005).
Miller, J. C. et al. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29, 143–148 (2011).
Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).
Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).
Weller, J., Pallaseni, A., Koeppel, J. & Parts, L. Predicting mutations generated by Cas9, base editing, and prime editing in mammalian cells. CRISPR J. 6, 325–338 (2023).
Glover, L., Jun, J. & Horn, D. Microhomology-mediated deletion and gene conversion in African trypanosomes. Nucleic Acids Res. 39, 1372–1380 (2011).
Kosicki, M. et al. Cas9-induced large deletions and small indels are controlled in a convergent fashion. Nat. Commun. 13, 3422 (2022).
Matsuzaki, S., Sakuma, T. & Yamamoto, T. REMOVER-PITCh: microhomology-assisted long-range gene replacement with highly multiplexed CRISPR–Cas9. In Vitro Cell. Dev. Biol. Anim. 60, 697–707 (2024).
Nakade, S. et al. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat. Commun. 5, 5560 (2014).
Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR–Cas system. Cell 163, 759–771 (2015).
Xin, C. et al. Comprehensive assessment of miniature CRISPR–Cas12f nucleases for gene disruption. Nat. Commun. 13, 5623 (2022).
Mulepati, S. & Bailey, S. In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target. J. Biol. Chem. 288, 22184–22192 (2013).
Morisaka, H. et al. CRISPR–Cas3 induces broad and unidirectional genome editing in human cells. Nat. Commun. 10, 5302 (2019).
Dolan, A. E. et al. Introducing a spectrum of long-range genomic deletions in human embryonic stem cells using type I CRISPR–Cas. Mol. Cell 74, 936–950 (2019).
Kotini, A. G. & Papapetrou, E. P. Engineering of targeted megabase-scale deletions in human induced pluripotent stem cells. Exp. Hematol. 87, 25–32 (2020).
Essletzbichler, P. et al. Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line. Genome Res. 24, 2059–2065 (2014).
Lee, H. J., Kim, E. & Kim, J.-S. Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res. 20, 81–89 (2010).
Chen, X. et al. Dual sgRNA-directed gene knockout using CRISPR/Cas9 technology in Caenorhabditis elegans. Sci. Rep. 4, 7581 (2014).
Canver, M. C. et al. Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. J. Biol. Chem. 289, 21312–21324 (2014).
Shou, J., Li, J., Liu, Y. & Wu, Q. Precise and predictable CRISPR chromosomal rearrangements reveal principles of Cas9-mediated nucleotide insertion. Mol. Cell 71, 498–509 (2018).
Kraft, K. et al. Deletions, inversions, duplications: engineering of structural variants using CRISPR/Cas in mice. Cell Rep. 10, 833–839 (2015).
Ann Ran, F. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380–1389 (2013).
Leibowitz, M. L. et al. Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing. Nat. Genet. 53, 895–905 (2021).
Lazar, N. H. et al. High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing. Nat. Genet. 56, 1482–1493 (2024).
Adikusuma, F. et al. Large deletions induced by Cas9 cleavage. Nature 560, E8–E9 (2018).
Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765–771 (2018).
Zuccaro, M. V. et al. Allele-specific chromosome removal after Cas9 cleavage in human embryos. Cell 183, 1650–1664 (2020).
Gonatopoulos-Pournatzis, T. et al. Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9–Cas12a platform. Nat. Biotechnol. 38, 638–648 (2020).
du Rand, A. et al. Highly efficient CRISPR/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa. Bioeng. Transl. Med. 9, e10640 (2024).
Blayney, J. et al. Unexpectedly high levels of inverted re-insertions using paired sgRNAs for genomic deletions. Methods Protoc. 3, 53 (2020).
Guo, T. et al. Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing. Genome Biol. 19, 170 (2018).
Ousterout, D. G. et al. Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat. Commun. 6, 6244 (2015).
Young, C. S. et al. A single CRISPR–Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell 18, 533–540 (2016).
Tycko, J. et al. 317. Screening S. aureus CRISPR–Cas9 paired-guide RNAs for efficient targeted deletion in Duchenne muscular dystrophy. Mol. Ther. 24, S127–S128 (2016).
Eleveld, T. F. et al. Engineering large-scale chromosomal deletions by CRISPR–Cas9. Nucleic Acids Res. 49, 12007–12016 (2021).
Geng, K. et al. Target-enriched nanopore sequencing and de novo assembly reveals co-occurrences of complex on-target genomic rearrangements induced by CRISPR–Cas9 in human cells. Genome Res. 32, 1876–1891 (2022).
Yan, J. et al. Improving prime editing with an endogenous small RNA-binding protein. Nature 628, 639–647 (2024).
Choi, J. et al. Precise genomic deletions using paired prime editing. Nat. Biotechnol. 40, 218–226 (2022).
Kweon, J. et al. Targeted genomic translocations and inversions generated using a paired prime editing strategy. Mol. Ther. 31, 249–259 (2023).
Lin, Q. et al. High-efficiency prime editing with optimized, paired pegRNAs in plants. Nat. Biotechnol. 39, 923–927 (2021).
Tao, R. et al. WT-PE: prime editing with nuclease wild-type Cas9 enables versatile large-scale genome editing. Signal Transduct. Target. Ther. 7, 108 (2022).
Jiang, T., Zhang, X.-O., Weng, Z. & Xue, W. Deletion and replacement of long genomic sequences using prime editing. Nat. Biotechnol. 40, 227–234 (2022).
Wang, J. et al. Efficient targeted insertion of large DNA fragments without DNA donors. Nat. Methods 19, 331–340 (2022).
Zhang, R. et al. Amplification editing enables efficient and precise duplication of DNA from short sequence to megabase and chromosomal scale. Cell 187, 3936–3952 (2024).
Jiao, Y. et al. Targeted, programmable, and precise tandem duplication in the mammalian genome. Genome Res. 33, 779–786 (2023).
Kilby, N. J., Snaith, M. R. & Murray, J. A. Site-specific recombinases: tools for genome engineering. Trends Genet. 9, 413–421 (1993).
Sternberg, N. & Hamilton, D. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J. Mol. Biol. 150, 467–486 (1981).
Meinke, G., Bohm, A., Hauber, J., Pisabarro, M. T. & Buchholz, F. Cre recombinase and other tyrosine recombinases. Chem. Rev. 116, 12785–12820 (2016).
Golic, K. G. & Lindquist, S. The FLP recombinase of yeast catalyzes site-specific recombination in the Drosophila genome. Cell 59, 499–509 (1989).
Sauer, B. & McDermott, J. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages. Nucleic Acids Res. 32, 6086–6095 (2004).
Karimova, M. et al. Vika/vox, a novel efficient and specific Cre/loxP-like site-specific recombination system. Nucleic Acids Res. 41, e37 (2013).
Chiu, T.-Y. & Jiang, J.-H. R. Logic synthesis of recombinase-based genetic circuits. Sci. Rep. 7, 12873 (2017).
Brown, W. R. A., Lee, N. C. O., Xu, Z. & Smith, M. C. M. Serine recombinases as tools for genome engineering. Methods 53, 372–379 (2011).
Liberante, F. G. & Ellis, T. From kilobases to megabases: design and delivery of large DNA constructs into mammalian genomes. Curr. Opin. Syst. Biol. 25, 1–10 (2021).
Xu, Z. et al. Accuracy and efficiency define Bxb1 integrase as the best of fifteen candidate serine recombinases for the integration of DNA into the human genome. BMC Biotechnol. 13, 87 (2013).
Durrant, M. G. et al. Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome. Nat. Biotechnol. 41, 488–499 (2023).
Gaidukov, L. et al. A multi-landing pad DNA integration platform for mammalian cell engineering. Nucleic Acids Res. 46, 4072–4086 (2018).
Yarnall, M. T. N. et al. Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases. Nat. Biotechnol. 41, 500–512 (2023).
Pandey, S. et al. Efficient site-specific integration of large genes in mammalian cells via continuously evolved recombinases and prime editing. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-024-01227-1 (2024).
Karpinski, J. et al. Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nat. Biotechnol. 34, 401–409 (2016).
Sarkar, I., Hauber, I., Hauber, J. & Buchholz, F. HIV-1 proviral DNA excision using an evolved recombinase. Science 316, 1912–1915 (2007).
Mukhametzyanova, L. et al. Activation of recombinases at specific DNA loci by zinc-finger domain insertions. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-02121-y (2024).
Durrant, M. G. et al. Bridge RNAs direct programmable recombination of target and donor DNA. Nature 630, 984–993 (2024).
Hiraizumi, M. et al. Structural mechanism of bridge RNA-guided recombination. Nature 630, 994–1002 (2024).
O’Gorman, S., Fox, D. T. & Wahl, G. M. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251, 1351–1355 (1991).
Seibler, J. & Bode, J. Double-reciprocal crossover mediated by FLP-recombinase: a concept and an assay. Biochemistry 36, 1740–1747 (1997).
Lee, E.-C. et al. Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery. Nat. Biotechnol. 32, 356–363 (2014).
Kameyama, Y., Kawabe, Y., Ito, A. & Kamihira, M. An accumulative site-specific gene integration system using Cre recombinase-mediated cassette exchange. Biotechnol. Bioeng. 105, 1106–1114 (2010).
Leprince, A., de Lorenzo, V., Völler, P., van Passel, M. W. J. & dos Santos, V. A. P. M. Random and cyclical deletion of large DNA segments in the genome of Pseudomonas putida. Environ. Microbiol. 14, 1444–1453 (2012).
Luo, G., Ivics, Z., Izsvák, Z. & Bradley, A. Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 95, 10769–10773 (1998).
Horie, K. et al. Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol. Cell. Biol. 23, 9189–9207 (2003).
Keng, V. W. et al. Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. Nat. Methods 2, 763–769 (2005).
Ruf, S. et al. Large-scale analysis of the regulatory architecture of the mouse genome with a transposon-associated sensor. Nat. Genet. 43, 379–386 (2011).
Kokubu, C. et al. A transposon-based chromosomal engineering method to survey a large cis-regulatory landscape in mice. Nat. Genet. 41, 946–952 (2009).
Dauban, L. et al. Genome–nuclear lamina interactions are multivalent and cooperative. Preprint at bioRxiv https://doi.org/10.1101/2024.01.10.574825 (2024).
Bilodeau, M., Girard, S., Hébert, J. & Sauvageau, G. A retroviral strategy that efficiently creates chromosomal deletions in mammalian cells. Nat. Methods 4, 263–268 (2007).
Su, H., Wang, X. & Bradley, A. Nested chromosomal deletions induced with retroviral vectors in mice. Nat. Genet. 24, 92–95 (2000).
Zheng, B., Sage, M., Sheppeard, E. A., Jurecic, V. & Bradley, A. Engineering mouse chromosomes with Cre–loxP: range, efficiency, and somatic applications. Mol. Cell. Biol. 20, 648–655 (2000).
Bradley, A. et al. The mammalian gene function resource: the International Knockout Mouse Consortium. Mamm. Genome 23, 580–586 (2012).
Peterson, K. A. & Murray, S. A. Progress towards completing the mutant mouse null resource. Mamm. Genome 33, 123–134 (2022).
Huang, X. et al. Single-cell, whole-embryo phenotyping of mammalian developmental disorders. Nature 623, 772–781 (2023).
Paranjape, N. et al. A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion. Sci. Rep. 13, 7689 (2023).
Torres, R. et al. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system. Nat. Commun. 5, 3964 (2014).
Aparicio-Prat, E. et al. DECKO: single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs. BMC Genomics 16, 846 (2015).
Zhu, S. et al. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library. Nat. Biotechnol. 34, 1279–1286 (2016).
Chen, H. V. et al. Deletion mapping of regulatory elements for GATA3 in T cells reveals a distal enhancer involved in allergic diseases. Am. J. Hum. Genet. 110, 703–714 (2023).
Gasperini, M. et al. CRISPR/Cas9-mediated scanning for regulatory elements required for HPRT1 expression via thousands of large, programmed genomic deletions. Am. J. Hum. Genet. 101, 192–205 (2017).
Brosh, R. et al. Synthetic regulatory genomics uncovers enhancer context dependence at the Sox2 locus. Mol. Cell 83, 1140–1152 (2023).
Ordoñez, R. et al. Genomic context sensitizes regulatory elements to genetic disruption. Mol. Cell 84, 1842–1854 (2024).
Camellato, B. R., Brosh, R., Ashe, H. J., Maurano, M. T. & Boeke, J. D. Synthetic reversed sequences reveal default genomic states. Nature 628, 373–380 (2024).
Luthra, I. et al. Regulatory activity is the default DNA state in eukaryotes. Nat. Struct. Mol. Biol. 31, 559–567 (2024).
Koeppel, J. Understanding Genomes Through Engineered Structural Variation. PhD thesis, University of Cambridge (2024).
Zheng, B. et al. Engineering a mouse balancer chromosome. Nat. Genet. 22, 375–378 (1999).
Oster, I. I. A new crossing-over suppressor in chromosome 2 effective in the presence of heterologous inversions. Drosoph. Inf. Serv. 30, 145 (1956).
Ghavi-Helm, Y. et al. Highly rearranged chromosomes reveal uncoupling between genome topology and gene expression. Nat. Genet. 51, 1272–1282 (2019).
Ghavi-Helm, Y. Functional consequences of chromosomal rearrangements on gene expression: not so deleterious after all? J. Mol. Biol. 432, 665–675 (2020).
Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011).
Korbel, J. O. & Campbell, P. J. Criteria for inference of chromothripsis in cancer genomes. Cell 152, 1226–1236 (2013).
Cortés-Ciriano, I. et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat. Genet. 52, 331–341 (2020).
Ijaz, J. et al. Haplotype-specific assembly of shattered chromosomes in esophageal adenocarcinomas. Cell Genom. 4, 100484 (2024).
Dymond, J. S. et al. Synthetic chromosome arms function in yeast and generate phenotypic diversity by design. Nature 477, 471–476 (2011).
Schraivogel, D., Steinmetz, L. M. & Parts, L. Pooled genome-scale CRISPR screens in single cells. Annu. Rev. Genet. 57, 223–244 (2023).
Riesenberg, S. et al. Efficient high-precision homology-directed repair-dependent genome editing by HDRobust. Nat. Methods 20, 1388–1399 (2023).
Pallaseni, A. et al. The interplay of DNA repair context with target sequence predictably biases Cas9-generated mutations. Nat. Commun. (in press).
Yu, Y. & Bradley, A. Engineering chromosomal rearrangements in mice. Nat. Rev. Genet. 2, 780–790 (2001).
Stoilov, L. M., Mirkova, V. N., Dimitrova, A., Uzunova, V. & Gecheff, K. I. Restriction endonucleases induce chromosomal aberrations in barley. Mutagenesis 11, 119–123 (1996).
Zhang, Y. et al. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 148, 908–921 (2012).
Liu, Y. et al. Global chromosome rearrangement induced by CRISPR–Cas9 reshapes the genome and transcriptome of human cells. Nucleic Acids Res. 50, 3456–3474 (2022).
Zou, R. S. et al. Massively parallel genomic perturbations with multi-target CRISPR interrogates Cas9 activity and DNA repair at endogenous sites. Nat. Cell Biol. 24, 1433–1444 (2022).
Mardin, B. R. et al. A cell-based model system links chromothripsis with hyperploidy. Mol. Syst. Biol. 11, 828 (2015).
Acknowledgements
We thank T. Ellis and members of the Parts laboratory for comments on the text. All authors were supported by Wellcome (220540/Z/20/A).
Author information
Authors and Affiliations
Contributions
J.K., J.W., T.V. and L.P. drafted the initial version; J.K. and J.W. created the figures; J.K., J.W., T.V. and L.P. wrote the text.
Corresponding author
Ethics declarations
Competing interests
L.P. receives remuneration and stock options from ExpressionEdits. The remaining authors do not declare competing interests.
Peer review
Peer review information
Nature Genetics thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Koeppel, J., Weller, J., Vanderstichele, T. et al. Engineering structural variants to interrogate genome function. Nat Genet 56, 2623–2635 (2024). https://doi.org/10.1038/s41588-024-01981-7
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41588-024-01981-7
This article is cited by
-
Identification of multiple genomic alterations and prediction of neoantigens from circulating tumor cells at the single-cell level
Nature Communications (2025)
-
Lactuca super-pangenome provides insights into lettuce genome evolution and domestication
Nature Communications (2025)


